@article{article, title  = {{Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2021}},

 month = {{9}},

 author = {{Peters S and Danson S and Ejedepang D and Dafni U and Hasan B and Radcliffe H-S and Bustin F and Crequit J and Coate L and Guillot M and Surmont V et al}},

 doi = {{10.1016/j.lungcan.2021.09.002}},

 volume = {{161}},

 journal = {{Lung Cancer}},

 pages = {{76-85}},

 note = {{Accessed on 2024/12/26}}}